Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Latest Articles

  • Nanoveu Secures $2 Million to Fast-Track Commercial Launch of ECS-DoT Chip and AIoT Platform
    Nanoveu Secures $2 Million to Fast-Track Commercial Launch of ECS-DoT Chip and AIoT Platform
    • News

  • Archer Unlocks Cryogenic Sensor Breakthrough for Quantum Computing
    Archer Unlocks Cryogenic Sensor Breakthrough for Quantum Computing
    • News

  • EGL Secures $1.9M PFAS Plant Contract as Demand for Clean-Up Technologies Surges
    EGL Secures $1.9M PFAS Plant Contract as Demand for Clean-Up Technologies Surges
    • News

  • RocketDNA Secures Major Aerial Tech Contract with Vault Minerals at WA Gold Site
    RocketDNA Secures Major Aerial Tech Contract with Vault Minerals at WA Gold Site
    • News

  • BirdDog Boosts Buy-Back Offer by 40% Ahead of ASX Delisting Vote
    BirdDog Boosts Buy-Back Offer by 40% Ahead of ASX Delisting Vote
    • News

  • AML3D Launches High-Tech U.S. Facility to Power Submarine Supply Chain
    AML3D Launches High-Tech U.S. Facility to Power Submarine Supply Chain
    • News

  • Vection Enters $520K Agritech Deal to Build AI-Powered Farming Robot
    Vection Enters $520K Agritech Deal to Build AI-Powered Farming Robot
    • News

  • Unith Achieves Strong Growth in Platform Usage and Strategic Partnerships
    Unith Achieves Strong Growth in Platform Usage and Strategic Partnerships
    • News

  • FBR and Samsung Heavy Industries Execute Engineering Service Agreement for Shipbuilding Automation Project
    FBR and Samsung Heavy Industries Execute Engineering Service Agreement for Shipbuilding Automation Project
    • News

  • Bioxyne Lifts FY2025 Revenue Forecast as Psychedelics and Pharma Push Gains Pace
    Bioxyne Lifts FY2025 Revenue Forecast as Psychedelics and Pharma Push Gains Pace
    • News

Grow Daily, Grow Quarterly- Nutritional Growth Solutions living up to their name

  • In News
  • February 1, 2022
  • Samantha Freidin
Grow Daily, Grow Quarterly- Nutritional Growth Solutions living up to their name

Global paedeatric nutrition company Nutritional Growth Solutions (ASX: NGS) are doing just that- growing.

The Company creates a proprietary line of supplements scientifically formulated to enhance and support growth in children that has expanded significantly both in range and distribution locales.

The clinically proven supplement range was formulated based on research into paediatric nutrition at Israel’s largest paediatric hospital. NGS’ ‘Healthy Height’ range is clinically proven to increase growth in 3 to 9 year old children by 13% – 34%.

Prior to NGS, there have been no sufficiently studied supplement options available for healthy, short and lean children who do not meet the criteria for growth hormone therapy.

December proved particularly successful for the Company which reported record revenue and cash receipts, spurred by positive feedback from their US launch and 300% increase in sales on the Company’s Tmall flagship store in China.

Quarterly cash receipts came in at a 36% increase on the prior corresponding period to USD $640k, with revenue just behind at USD $570k, a 38% increase.

A significant market, the US represents a key opportunity for the Company which will commence its retail expansion strategy this year. This includes a brand awareness campaign as well as the approval to sell the product on Walmart.com and RangeMe.com, two large retailers that will increase the reach of the brand. Walmart’s website received over 100 million unique visitors every month where NGS’ Healthy Heights Grow Daily 3+ single serve shake mixes will now be available. The complete Healthy Heights range will be made available on the RangeMe site, a platform used by over 10,000 major retailers such as Wholefoods, CVS Pharmacy, Target and 7- Eleven.

With an insatiable appetite for growth (see what I did there?) the Company is also planning to launch their products closer to home, continuing to progress with the manufacturing of products in New Zealand for the Asia Pacific region. Products are expected to come on line by the end of Q1 2022. Distribution in the region will be led by Australia Sunshine International Group which will see the Healthy Heights shake stocked in a variety of stores and eCommerce platforms such as JD.com (NASDAQ:JD), one of China’s largest online retailers by transaction volume and revenue.

Additionally, Ultrahealth Group will distribute the shakes on Kaola and Little Red Book, two more significant e-commerce platforms.

And there’s more..*insert another bad pun about growth here*. The Company is developing new products to add to their line including their Kidz Protein dairy-based and plant-based shake ranges, new Grow Daily 3+ nutrition bars and Ready-to-Drink Grow Daily 3+. Products are expected in Q2.

“The quarter has been focused on the manufacturing of our Healthy Heights products in New Zealand and ensuring the first production run is on time and available to fulfil out new distribution arrangements in Asia Pacific,” said Liron Fendell, Company CEO.

“The Ultrahealth and Australia Sunshine agreements signed this quarter symbolise a milestone in our growth strategy as we enter South East Asia and expand our footprint in China. We are in a strong position to reach our growth objectives with additional markets planned to launch Healthy Heights in 2022.”

The Company reported a cash balance of USD $4.1 million as at 31 December 2021.

  • About
  • Latest Posts
Samantha Freidin
Samantha Freidin is a business journalist at Emerald Financial whilst also completing a Masters of Marketing and Digital Communications at Monash University.
Latest posts by Samantha Freidin (see all)
  • Parkinson’s UK backs Pharmaxis with $5 million to slow the onset of incurable disease with ‘ground breaking’ trial - September 1, 2022
  • How this company is developing medtech to support Indigenous community health - August 22, 2022
  • A round of ap-paws for PharmAust, changing the ruff prognosis for dogs with lymphoma - August 17, 2022
  •  
  •  
  •  
  •  
  • asx ngs
  • Healthy Height
  • kaola
  • Liron Fendell
  • ngs
  • nutritional growth solutions
  • tmall
  • News

Leave a Comment

You must be logged in to post a comment.

  • About
  • Latest Posts
Samantha Freidin
Samantha Freidin is a business journalist at Emerald Financial whilst also completing a Masters of Marketing and Digital Communications at Monash University.
Latest posts by Samantha Freidin (see all)
  • Parkinson’s UK backs Pharmaxis with $5 million to slow the onset of incurable disease with ‘ground breaking’ trial - September 1, 2022
  • How this company is developing medtech to support Indigenous community health - August 22, 2022
  • A round of ap-paws for PharmAust, changing the ruff prognosis for dogs with lymphoma - August 17, 2022

Login or register for free to access unlimited reading

Register Now!
  • About
  • Latest Posts
Samantha Freidin
Samantha Freidin is a business journalist at Emerald Financial whilst also completing a Masters of Marketing and Digital Communications at Monash University.
Latest posts by Samantha Freidin (see all)
  • Parkinson’s UK backs Pharmaxis with $5 million to slow the onset of incurable disease with ‘ground breaking’ trial - September 1, 2022
  • How this company is developing medtech to support Indigenous community health - August 22, 2022
  • A round of ap-paws for PharmAust, changing the ruff prognosis for dogs with lymphoma - August 17, 2022
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.